I've addressed this in more detail in this post.Short answer is...

I've addressed this in more detail in this post.

Short answer is that there are two US listings:

• one is MNS dual listing onto OTC Best Market (that's what's happening in 4-6 weeks as they last announced).
• the full US listing onto Nasdaq or NYSE for IM3 is probably not going to happen until the private share price of IM3 is over $1/share and they receive first payments from some of their offtake agreements. This is a minimum requirement for listing on those exchanges.

Given that the Magnis website is undergoing maintenance, I imagine there will be an attempt to address The Australian articles once they update information there. There may be a legal/NDA angle to a few things that would mean we may not be able to receive an answer till it's fully resolved/settled.

Uncertainty isn't fun (except for The Australian who can endlessly fill the silence until they're told to move on to another topic/company), but no yellow flags about IM3 or C4V themselves, and as long as MNS is entitled to their 62% share of IM3 the value proposition is intact even if management needs upgrade in how they handle and communicate matters.